Citation Impact
Citing Papers
Effects of Medical Therapy on Insulin Resistance and the Cardiovascular System in Polycystic Ovary Syndrome
2007
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
2010 Standout
Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome
2018 Standout
The effects of oxidative stress on female reproduction: a review
2012 Standout
Longitudinal assessment of antimüllerian hormone during pregnancy—relationship with maternal adiposity, insulin, and adiponectin
2009
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis
2010
Anti-TPO Antibodies Diffusion through the Placental Barrier during Pregnancy
2014
Anti-Müllerian hormone (AMH): Regulator and marker of ovarian function
2010
Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?
2010
Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society
2011
Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
2009
Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
2008
The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta‐analysis
2009
A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome
2011
Hidradenitis suppurativa: A comprehensive review
2009 Standout
Epidemiology of hirsutism among women of reproductive age in the community: a simplified scoring system
2012
Dermatology of androgen-related disorders
2006
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Metformin for the Treatment of the Polycystic Ovary Syndrome
2008
Granulosa Cell Production of Anti-Müllerian Hormone Is Increased in Polycystic Ovaries
2006
Ferriman Gallwey Self-Scoring I: Performance Assessment in Women with Polycystic Ovary Syndrome
2005
The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome
2009
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Are Women With Polycystic Ovarian Syndrome at a High Risk of Non-Alcoholic Fatty Liver Disease? A Meta-Analysis
2014
Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome
2008
Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapy
2007
Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review
2007
Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome
2006
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
The role of metformin in polycystic ovary syndrome: a systematic review
2007
Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
2010
Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians
2006
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Polycystic ovary syndrome in post-menopausal women—marker of the metabolic syndrome
2004
Equine Metabolic Syndrome
2010 Standout
Polycystic ovary syndrome in adolescence--a therapeutic conundrum
2004
Treatment of PCOS in adolescence
2006
Hirsutism
2005
Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: Do androgens play a role?
2009
Polycystic Ovary Syndrome
2005 Standout
Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis
2008
Exercise therapy in polycystic ovary syndrome: a systematic review
2010
Drug Insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome—a reappraisal
2008
Ovulation induction in polycystic ovary syndrome: Current options
2016
Polycystic ovary syndrome
1997
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open‐label parallel study
2008
Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones
2005
Polycystic ovary syndrome
2016 Standout
Polycystic Ovary Syndrome in Adolescence
2005
Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management
2005
Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients
2010
A systematic review of commonly used medical treatments for hirsutism in women
2007
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Anti-Mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome
2009
Hirsutism and acne in polycystic ovary syndrome
2004
Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality
2006
Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment
2008
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
2009 Standout
Anti-Mullerian hormone: a new marker for ovarian function
2005
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
2008
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
2012
A Trial in Progress: Gestational Diabetes
2007
Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy
2013
Health Consequences of Obesity in Youth: Childhood Predictors of Adult Disease
1998 Standout
Hidradenitis Suppurativa in 64 Female Patients: Retrospective Study Comparing Oral Antibiotics and Antiandrogen Therapy
2007
Consensus on women's health aspects of polycystic ovary syndrome (PCOS)
2011
Serum Anti-Mullerian Hormone Concentrations Are Elevated in Oligomenorrheic Girls without Evidence of Hyperandrogenism
2010
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
The use of metformin for women with PCOS undergoing IVF treatment
2006
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
2012
Drug treatments for polycystic ovary syndrome.
2009
Interventions for hirsutism (excluding laser and photoepilation therapy alone)
2015
Prospective Parallel Randomized, Double-Blind, Double-Dummy Controlled Clinical Trial Comparing Clomiphene Citrate and Metformin as the First-Line Treatment for Ovulation Induction in Nonobese Anovulatory Women with Polycystic Ovary Syndrome
2005
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Genetic Basis of Metabolic Abnormalities in Polycystic Ovary Syndrome
2004
Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome
2007
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
2016
Works of L Harborne being referenced
Metformin and Weight Loss in Obese Women with Polycystic Ovary Syndrome: Comparison of Doses
2005
Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome
2003
Metformin or Antiandrogen in the Treatment of Hirsutism in Polycystic Ovary Syndrome
2003
Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment
2005
Outcomes of pregnancy complicated by thyroid disease
2005
The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome
2008